U.S. flag

An official website of the United States government

NM_144997.7(FLCN):c.1657T>C (p.Trp553Arg) AND Hereditary cancer-predisposing syndrome

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Dec 13, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000492176.4

Allele description [Variation Report for NM_144997.7(FLCN):c.1657T>C (p.Trp553Arg)]

NM_144997.7(FLCN):c.1657T>C (p.Trp553Arg)

Gene:
FLCN:folliculin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17p11.2
Genomic location:
Preferred name:
NM_144997.7(FLCN):c.1657T>C (p.Trp553Arg)
HGVS:
  • NC_000017.11:g.17213738A>G
  • NG_008001.2:g.28451T>C
  • NM_001353229.2:c.1711T>C
  • NM_001353230.2:c.1657T>C
  • NM_001353231.2:c.1657T>C
  • NM_144997.7:c.1657T>CMANE SELECT
  • NP_001340158.1:p.Trp571Arg
  • NP_001340159.1:p.Trp553Arg
  • NP_001340160.1:p.Trp553Arg
  • NP_659434.2:p.Trp553Arg
  • LRG_325t1:c.1657T>C
  • LRG_325:g.28451T>C
  • NC_000017.10:g.17117052A>G
  • NM_144997.5:c.1657T>C
Protein change:
W553R
Links:
dbSNP: rs1131690833
NCBI 1000 Genomes Browser:
rs1131690833
Molecular consequence:
  • NM_001353229.2:c.1711T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353230.2:c.1657T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353231.2:c.1657T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_144997.7:c.1657T>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000580742Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Likely pathogenic
(Dec 13, 2023)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Crystal structure of folliculin reveals a hidDENN function in genetically inherited renal cancer.

Nookala RK, Langemeyer L, Pacitto A, Ochoa-MontaƱo B, Donaldson JC, Blaszczyk BK, Chirgadze DY, Barr FA, Bazan JF, Blundell TL.

Open Biol. 2012 Aug;2(8):120071. doi: 10.1098/rsob.120071.

PubMed [citation]
PMID:
22977732
PMCID:
PMC3438538

Folliculin - A tumor suppressor at the intersection of metabolic signaling and membrane traffic.

Dodding MP.

Small GTPases. 2017 Apr 3;8(2):100-105. doi: 10.1080/21541248.2016.1204808. Epub 2016 Jun 29. Review.

PubMed [citation]
PMID:
27355777
PMCID:
PMC5464117
See all PubMed Citations (3)

Details of each submission

From Ambry Genetics, SCV000580742.6

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

The p.W553R variant (also known as c.1657T>C), located in coding exon 11 of the FLCN gene, results from a T to C substitution at nucleotide position 1657. The tryptophan at codon 553 is replaced by arginine, an amino acid with dissimilar properties. This alteration has been observed in multiple individuals with a personal or family history that is consistent with FLCN-associated disease (Ambry internal data). Based on internal structural assessment, this alteration disrupts the C-terminal DENN-like domain, which is a guanine nucleotide exchange factor implicated in FLCN’s role in membrane trafficking (Ambry internal data; Nookala RK et al. Open Biol, 2012 Aug;2:120071; Dodding MP. Small GTPases, 2017 04;8:100-105; Schmidt LS et al. Gene, 2018 Jan;640:28-42). This amino acid position is highly conserved in available vertebrate species. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 3, 2024